Homepage » Asturfeito Runs for a Cause! 🧡
NEWS

Asturfeito Runs for a Cause! 🧡

18.02.25 – Asturfeito joins 41,000 runners across Asturias for ‘Corre con Galbán’ race to raise funds for childhood cancer research. The race, held in 78 municipalities simultaneously, was a resounding success in its 7th edition.

 

On 16th February, Asturfeito colleagues and their families took to the streets of Gijón, joining the Solidarity Run ‘Corre con Galbán’. Together, we helped turn the city orange, raising awareness of childhood cancer and supporting research efforts to combat this disease.

We are truly grateful to everyone who participated—whether by running, walking, or simply cheering on the cause. Your commitment and generosity once again made it possible for us to contribute to this initiative, reinforcing the belief that at Asturfeito, solidarity is a value that brings us together.

We invite you to relive some of the moments from this special day through the images we’ve shared. It was a day of effort, emotion, and community spirit, proving that small actions can have a big impact.

Thank you for being part of this movement!

 

you may also like
RELATED NEWS
AF - NEWS
Asturfeito moves forward to the manufacturing phase of the VATIST project for IFMIF-DONES

17.04.2026 – The DONES-TCO consortium, led by Asturfeito and also formed by Empresarios Agrupados Internacional and Ingecid, has successfully completed the design phase of the VATIST project for IFMIF-DONES.

AF - NEWS
Asturfeito continues to advance its capacity expansion plan with new facilities at the Port of Avilés

13.03.2026 – Asturfeito’s new facilities at the Port of Avilés represent another step forward in the company’s investment plan to strengthen its industrial, logistics and production capabilities.

AF - NEWS
Asturfeito employees raise €3,000 for breast cancer research

18.11.2025 – Over 5,500 kilometres, 40 employees involved and €3,000 raised for the fight against breast cancer. Once again this year, we are collaborating with the Spanish Association Against Cancer.